Northeast Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 6/6
Northeast Pharmaceutical Group has a total shareholder equity of CN¥5.2B and total debt of CN¥2.4B, which brings its debt-to-equity ratio to 45.7%. Its total assets and total liabilities are CN¥15.6B and CN¥10.4B respectively. Northeast Pharmaceutical Group's EBIT is CN¥352.2M making its interest coverage ratio -4.6. It has cash and short-term investments of CN¥5.8B.
Key information
45.7%
Debt to equity ratio
CN¥2.39b
Debt
Interest coverage ratio | -4.6x |
Cash | CN¥5.82b |
Equity | CN¥5.23b |
Total liabilities | CN¥10.37b |
Total assets | CN¥15.61b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 000597's short term assets (CN¥10.3B) exceed its short term liabilities (CN¥9.9B).
Long Term Liabilities: 000597's short term assets (CN¥10.3B) exceed its long term liabilities (CN¥459.0M).
Debt to Equity History and Analysis
Debt Level: 000597 has more cash than its total debt.
Reducing Debt: 000597's debt to equity ratio has reduced from 83.8% to 45.7% over the past 5 years.
Debt Coverage: 000597's debt is well covered by operating cash flow (23.7%).
Interest Coverage: 000597 earns more interest than it pays, so coverage of interest payments is not a concern.